2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in Adults
- Resource Type
- Practice Guideline
- Authors
- Mancini, G.B. John; O’Meara, Eileen; Zieroth, Shelley; Bernier, Mathieu; Cheng, Alice Y.Y.; Cherney, David Z.I.; Connelly, Kim A.; Ezekowitz, Justin; Goldenberg, Ronald M.; Leiter, Lawrence A.; Nesrallah, Gihad; Paty, Breay W.; Piché, Marie-Eve; Senior, Peter; Sharma, Abhinav; Verma, Subodh; Woo, Vincent; Darras, Pol; Gabor, Jonathan Y.; Grégoire, Jean; Lonn, Eva; Stone, James A.; Yale, Jean-François; Yeung, Colin; Zimmerman, Deborah
- Source
- In Canadian Journal of Cardiology August 2022 38(8):1153-1167
- Subject
- Language
- ISSN
- 0828-282X